Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03955939 |
| Title | A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body |
| Recruitment | Completed |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Eli Lilly and Company |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010-0269 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | United States | Details | |
| South Texas Accelerated Research Therapeutics, LLC | San Antonio | Texas | 78229-3307 | United States | Details | |
| Cliniques Universitaires Saint-Luc | Brussels | 1200 | Belgium | Details | ||
| Universitair Ziekenhuis Antwerpen | Edegem | 2650 | Belgium | Details | ||
| Universitair Ziekenhuis Gent | Gent | 9000 | Belgium | Details | ||
| Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg | Leuven | 3000 | Belgium | Details |